| ★ | Hair Loss Update 2026: JAK Inhibitors, Oral Minoxidil, and Sequencing | | 209 | Estados Unidos | |
| 19 | ABTECT Maintenance Data Show Durable Remission in UC, With Remo Panaccione, MD | | 60.1K | Estados Unidos | 67 |
| 6 | Furoscix ReadyFlow (Furosemide) and its Impact on HF, CKD Edema Treatment | | 374 | Estados Unidos | 71 |
| 4 | Inhaled Treprostinil for IPF: TETON-1 Phase 3 Results With Steven Nathan, MD | ATS 2026 | | 301 | Estados Unidos | 72 |
| 16 | GP-SOD Plus Targeted Phototherapy Improves Vitiligo Repigmentation | | 249 | Estados Unidos | 68 |
| 10 | Why Fewer Than Half of Referred Patients Reach Kidney Transplant Evaluation | | 217 | Estados Unidos | 69 |
| 18 | How Much Hair Regrowth Did Upadacitinib Achieve in Severe Alopecia Areata? | | 196 | Estados Unidos | 67 |
| 17 | SYNCHRONIZE-1: Survodutide Achieves Significant Weight Loss Versus Placebo | | 174 | Estados Unidos | 67 |
| 11 | Highlighting FDA-Approved Therapies in Atopic Dermatitis, With Chris Bunick, MD, PhD | | 152 | Estados Unidos | 68 |
| 20 | Secondary Analyses of OCEANIC-STROKE Confirm Efficacy of Asundexian | | 113 | Estados Unidos | 67 |
| 15 | Sotatercept May Improve RV Function in Group 3 3 Pulmonary Hypertension | | 112 | Estados Unidos | 68 |
| 8 | How a Nephrologist Diagnoses and Manages Chronic Kidney Disease | | 70 | Estados Unidos | 71 |
| 3 | Addressing Advances and Roadblocks in Lipid Management, With Joseph Saseen, PharmD | | 64 | Estados Unidos | 73 |
| 12 | How Well-Being in Psoriasis is Being Assessed Via WHO-5, With Ulrich Mrowietz, MD | | 56 | Estados Unidos | 68 |
| 1 | Spotting Scarring Alopecia Before It's Too Late | | 42 | Estados Unidos | 75 |
| 9 | Treating Peanut Allergy in Infants: Douglas Mack, MD, on the Upcoming THRIVE Trial | | 31 | Estados Unidos | 70 |
| 7 | Addressing the Manifold Barriers in Hypertension, With Michael Miedema, MD | | 27 | Estados Unidos | 71 |
| 14 | Why Quality of Life Can't Take a Back Seat in ISM: Thanai Pongdee, MD, on New PIONEER Data | | 27 | Estados Unidos | 68 |
| 2 | Brief, Regular Movement Breaks Can Improve Cardiovascular Risk in T2D | | 24 | Estados Unidos | 74 |
| 13 | IBS-C Treatment Cycling Linked to Higher Healthcare Utilization | | 23 | Estados Unidos | 68 |
| 5 | What's Next for Peanut Allergy Microneedle Immunotherapy, With Brian Vickery, MD | | 12 | Estados Unidos | 72 |